An intensive research training program focused on cancer immunotherapy, specifically studying immune checkpoint inhibitors (ICIs) in lung and esophageal cancers. The program combines laboratory research with clinical applications, offering comprehensive training in cancer immunology and therapeutic development.
Cutting-edge research in cancer immunotherapy
Integration of basic science and clinical applications
Access to state-of-the-art laboratory facilities
Hands-on experience with advanced research techniques
Collaboration with clinical trials
Direct mentorship from leading researchers
Master fundamental concepts of tumor immunology
Develop expertise in ICI mechanisms and applications
Learn advanced laboratory techniques in immunology
Understand clinical trial design and implementation
Gain experience in translational research
Develop scientific writing and presentation skills
Key Research Areas:
1. Mechanisms of immune checkpoint inhibition in lung and esophageal cancers
2. Biomarker development for immunotherapy response prediction
3. Combination therapy strategies to enhance ICI efficacy
Current Projects:
1. "Identification of novel biomarkers for ICI response in esophageal cancer"
2. "Development of combination strategies to overcome ICI resistance"
"Study of tumor microenvironment in lung cancer immunotherapy"
Undergraduate students：
Candidates should be enrolled in a bachelor's degree program in biology, biochemistry, or a related field. Prior coursework in molecular biology or immunology is preferred. Basic proficiency in English is required.
Graduate students：
Candidates must be enrolled in a Master’s, M.D. or Ph.D. program in biomedicine, immunology, or a related field. Familiarity with research methodologies and laboratory techniques is required. Fluency in English is mandatory.
Researcher fellows：
Applicants should have an advanced degree (M.Sc. M.D. Ph.D. or equivalent) in a biomedical discipline with some prior research experience. Candidates must demonstrate an ability to work independently and contribute to team projects. Proficiency in English is essential.
Doctors：
Candidates must hold an M.D. degree with clinical experience, preferably in oncology or internal medicine. Research experience is not mandatory but is a strong advantage. Applicants must be fluent in English.
Postdocs：
Postdoctoral fellows should have a Ph.D. in biomedicine, immunology, or an M.D. with clinical training in medicine, or the equivalent of education, training and experience. Candidates should be fluent in English.
Duration: 8 weeks
Daily Training Schedule (Example):
Monday:
9:00-10:30 Laboratory meeting
11:00-12:00 Technical training
14:00-17:00 Experimental work
Tuesday:
9:00-12:00 Research experiments
14:00-15:30 Journal club
16:00-17:00 Data analysis
Wednesday:
9:00-12:00 Clinical correlation meeting
14:00-17:00 Laboratory work
Thursday:
9:00-12:00 Research experiments
14:00-15:30 Scientific writing workshop
16:00-17:00 Individual mentoring
Friday:
9:00-10:30 Progress presentation
11:00-12:00 Group discussion
14:00-17:00 Laboratory work
Monthly progress reports
Research presentation evaluations
Laboratory technique assessments
Final project presentation
Publication contribution
Certificate upon successful completion
Regular feedback sessions with mentor
End-of-program evaluation survey
The program is free of charge.
Dr. TANG Jie